Aliskiren
Novartis-ST-01
Approved small_molecule completed
Quick answer
Aliskiren for IgA Nephropathy is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- IgA Nephropathy
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed